Refine your search

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

PSCI 21-038 Phase Ib Study of Brigatinib Plus Bevacizumab in Patients with ALK-rearranged Non-Small Cell Lung Cancer (NSCLC) Who Have Previously Progressed on Prior ALK-Directed Therapy

Clinical trial on the treatment of persons who are diagnosed with Lung Cancer.
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT04227028
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
lung cancer
Exclusion Criteria:
other cancer in the last 3 years
major surgery in the last 30 days
heart attack or stroke in the last 6 months
Cancer
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA